Rigidified acetylcholine mimics: Conformational requirements for binding to neuronal nicotinic receptors

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 21, 2003, Pages 3847-3851

  Villeneuve, Gérald ^a   Cécyre, Danielle ^b   Lejeune, Hélène ^b   Drouin, Marc ^a   Lan, Ruoxi ^a   Quirion, Rémi ^b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE DERIVATIVE; ALPHA BUNGAROTOXIN; CYTISINE; NICOTINIC RECEPTOR;

ARTICLE; BINDING AFFINITY; BINDING SITE; CARBON NUCLEAR MAGNETIC RESONANCE; CRYSTAL STRUCTURE; DRUG CONFORMATION; DRUG DESIGN; DRUG SYNTHESIS; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; STEREOSPECIFICITY; STRUCTURE ACTIVITY RELATION;

EID: 0141545058     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00728-5     Document Type: Article

References (20)

1. Hulme E.C., Birdsall N.J.M., Buckley N.J. Annu. Rev. Pharmacol. Toxicol. 30:1990;633.
2. Sargent P. Annu. Rev. Neurosci. 16:1993;403.
3. Seguela P., Wadiche J., Dineley-Miller K., Dani J.A., Patrick J.W. Eur. J. Neurosci. 13:1993;596.
4. Flores C.M., Rogers S.W., Pabreza L.A., Wolfe B.B., Kellar K.J. Mol. Pharmacol. 41:1992;31.
5. Coyle J.T., Price D.L., DeLong M. Science. 219:1983;1184.
6. Snape M.F., Misra A., Murray T.K., DeSouza R.J., Williams J.L., Cross A.J., Green A.R. Neuropharmacology. 38:1999;181.
7. Araujo D.M., Lapchak P.A., Meaney M.J., Collier B., Quirion R. J. Neurosci. 10:1990;3069.
8. Beers W.H., Reich E. Nature. 228:1970;917.
9. Thomas P., Stephens M., Wilkie G., Amar M., Lunt G.G., Whiting P., Gallagher T., Pereira E., Alkondon M., Albuquerque E.X. J. Neurochem. 60:1993;2308.
10. Quian C., Li T., Shen T.Y., Libertin-Garahan L., Eckman J., Biftu T., Ip S. Eur. J. Pharm. 250:1993;R13.
11. Crystallographic data for structures 9 and 29c have been deposited to the Cambridge Crystallographic Data Centre as supplementary publication numbers CCDC 205925 and 205926. Copies of the data can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (fax: +44-1223-336033 or e-mail: deposit@ccdc.cam.ac.uk).
12. Mancuso A.J., Huang S.L., Swern D. J. Org. Chem. 43:1978;2480.
13. 2): Linkert F., Laschat S., Kotila S., Fox T. Tetrahedron. 52:1995;955.
14. +-Me), 98.
15. Barlow R.B., Johnson O. Br. J. Pharmacol. 98:1989;799.
16. Corey E.J., Seebach D. Angew. Chem., Int. Ed. Engl. 4:1965;1075.
17. Stork G., Zhao K. Tetrahedron Lett. 30:1989;287. (addition of HCl prevent formation of amine-oxide).
18. Yamawaki J., Ando T. Chem. Lett. 1989;755.
19. 125I]α-BGT. 10 and 100 μM of Nic were used respectively to define the non-specific binding. Separation of bound from free radioactive ligand was performed by rapid filtration through #32 glass fiber filters (presoaked in 0.1% polyethyleneimine solution) under reduced pressure using a Brandell Cell Harvester followed by 3×4 mL rapid washes with 50 mM Tris buffer, pH 7.4 at 4°C. Bound radioactivity was determined via liquid scintillation.
20. Reavill C., Jenner P., Kumar R., Stolerman I.P. Neuropharmacology. 27:1988;235.